Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors

References

• (a) Reveglia P, Masi M, Evidente A. Melleins-intriguing natural compounds. Biomolecules 2020;10:772.
   PubMed Web of Science ®Google Scholar
  (b) Shabir G, Saeed A, El-Seedi HR. Natural isocoumarins: structural styles and biological activities, the revelations carry on. Phytochemistry 2021;181:112568.
   PubMed Web of Science ®Google Scholar
  (c) Pellissier L, Koval A, Marcourt L, et al. Isolation and identification of isocoumarin derivatives with specific inhibitory activity against Wnt pathway and metabolome characterization of Lasiodiplodia venezuelensis. Front Chem 2021;9:664489.
   PubMedGoogle Scholar
  (d) Coronado L, Zhang XQ, Dorta D, et al. Semisynthesis, antiplasmodial activity, and mechanism of action studies of isocoumarin derivatives. J Nat Prod 2021;84:1434–41.
   PubMed Web of Science ®Google Scholar
• (a) Weber A, Breugst M, Pietruszka J. Experimental and computational investigations of the reactions between α,β-unsaturated lactones and 1,3-dienes by cooperative Lewis acid/Brønsted acid catalysis. Angew Chem Int Ed Engl 2020;59:18709–16.
   PubMed Web of Science ®Google Scholar
  (b) Yata T, Nishimoto Y, Chiba K, Yasuda M. Indium-catalyzed C-F Bond transformation through oxymetalation/β-fluorine elimination to access fluorinated isocoumarins. Chemistry 2021;27:8232.
   PubMedGoogle Scholar
  (c) Saeed A, Larik FA. Metal-free synthesis of isocoumarins. Chem Heterocycl Compd 2016; 52:450–2.
   Web of Science ®Google Scholar
• (a) Riveiro ME, De Kimpe N, Moglioni A, et al. Coumarins: old compounds with novel promising therapeutic perspectives. Curr Med Chem 2010; 17:1325–38.
   PubMed Web of Science ®Google Scholar
  (b) Stefanachi A, Leonetti F, Pisani L, et al. Coumarin: a natural, privileged and versatile scaffold for bioactive compounds. Molecules 2018; 23:250.
   PubMed Web of Science ®Google Scholar
  (c) Carradori S, Secci D, Petzer JP. MAO inhibitors and their wider applications: a patent review. Expert Opin Ther Pat 2018; 28:211–26.
   PubMed Web of Science ®Google Scholar
  (d) Menezes JC, Diederich M. Translational role of natural coumarins and their derivatives as anticancer agents. Future Med Chem 2019; 11:1057–82.
   PubMed Web of Science ®Google Scholar
• (a) Giovannuzzi S, Hewitt CS, Nocentini A, et al. Coumarins effectively inhibit bacterial α-carbonic anhydrases. J Enzyme Inhib Med Chem 2022;37:333–8.
   PubMed Web of Science ®Google Scholar
  (b) Petreni A, Osman SM, Alasmary FA, et al. Binding site comparison for coumarin inhibitors and amine/amino acid activators of human carbonic anhydrases. Eur J Med Chem 2021;226:113875.
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders. J Enzyme Inhib Med Chem 2021;36:1702–14.
   PubMed Web of Science ®Google Scholar
  (d) Supuran CT. Coumarin carbonic anhydrase inhibitors from natural sources. J Enzyme Inhib Med Chem 2020;35:1462–70.
   PubMed Web of Science ®Google Scholar
• Lippi G, Gosselin R, Favaloro EJ. Current and emerging direct oral anticoagulants: state-of-the-Art. Semin Thromb Hemost 2019;45:490–501.
   PubMed Web of Science ®Google Scholar
• (a) Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009; 131:3057–62.
   PubMed Web of Science ®Google Scholar
  (b) Vu H, Pham NB, Quinn RJ. Direct screening of natural product extracts using mass spectrometry. J Biomol Screen 2008; 13:265–75.
   PubMed Web of Science ®Google Scholar
  (c) Maresca A, Temperini C, Pochet L, et al. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010;53:335–44.
   PubMed Web of Science ®Google Scholar
  (d) Nocentini A, Angeli A, Carta F, et al. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021;36:561–80.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• a) Draghici B, Vullo D, Akocak S, et al. Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect. Chem Commun (Camb) 2014;50:5980–3.
   PubMed Web of Science ®Google Scholar
  (b) Akocak S, Lolak N, Vullo D, et al. Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators. J Enzyme Inhib Med Chem 2017;32:1305–12.
   PubMed Web of Science ®Google Scholar
  (c) Akocak S, Lolak N, Bua S, et al. α-Carbonic anhydrases are strongly activated by spinaceamine derivatives. Bioorg Med Chem 2019;27:800–4.
   PubMed Web of Science ®Google Scholar
  (d) Akocak S, Lolak N, Bua S, et al. Activation of human α-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives. J Enzyme Inhib Med Chem 2019;34:1193–8.
   PubMed Web of Science ®Google Scholar
• (a) Carradori S, Secci D, De Monte C, et al. A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms. Bioorg Med Chem 2016;24:1095–105.
   PubMed Web of Science ®Google Scholar
  (b) Nocentini A, Bua S, Lomelino CL, et al. Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases. ACS Med Chem Lett 2017;8:1314–9.
   PubMed Web of Science ®Google Scholar
  (c) Winum JY, Temperini C, El Cheikh K, et al. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. J Med Chem 2006;49:7024–31.
   PubMed Web of Science ®Google Scholar
  (d) Casey JR, Morgan PE, Vullo D, et al. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. J Med Chem 2004; 47:2337–47.
   PubMed Web of Science ®Google Scholar
• (a) Pastorekova S, Casini A, Scozzafava A, et al. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg Med Chem Lett 2004;14:869–73.
   PubMed Web of Science ®Google Scholar
  (b) Akocak S, Lolak N, Bua S, et al. Synthesis and biological evaluation of novel N,N'-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors. Bioorg Chem 2018;77:245–51.
   PubMed Web of Science ®Google Scholar
  (c) Akocak S, Alam MR, Shabana AM, et al. PEGylated bis-sulfonamide carbonic anhydrase inhibitors can efficiently control the growth of several carbonic anhydrase IX-expressing carcinomas. J Med Chem 2016;59:5077–88.
   PubMed Web of Science ®Google Scholar
• (a) Oztürk Sarikaya SB, Topal F, Sentürk M, et al. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds. Bioorg Med Chem Lett 2011;21:4259–62.
   PubMed Web of Science ®Google Scholar
  (b) Lolak N, Akocak S, Bua S, Supuran CT. Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors. Bioorg Chem 2019; 82:117–22.
   PubMed Web of Science ®Google Scholar
  (c) Lolak N, Akocak S, Bua S, et al. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors. Bioorg Med Chem 2019; 27:1588–94.
   PubMed Web of Science ®Google Scholar
• (a) Krall N, Pretto F, Decurtins W, et al. A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors . Angew Chem Int Ed Engl 2014; 53:4231–5.
   PubMed Web of Science ®Google Scholar
  (b) Clare BW, Supuran CT. Carbonic anhydrase activators. 3: structure-activity correlations for a series of isozyme II activators. J Pharm Sci 1994; 83:768–73.
   PubMed Web of Science ®Google Scholar
  (c) Dubois L, Peeters S, Lieuwes NG, et al. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiother Oncol 2011; 99:424–31.
   PubMed Web of Science ®Google Scholar
• (a) Gulçin İ, Abbasova M, Taslimi P, et al. Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors. J Enzyme Inhib Med Chem 2017;32:1174–82.
   PubMed Web of Science ®Google Scholar
  (b) Guzel-Akdemir O, Akdemir A, Karali N, et al. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII. Org Biomol Chem 2015;13:6493–9.
   PubMed Web of Science ®Google Scholar
  (c) Pacchiano F, Carta F, McDonald PC, et al. Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem 2011;54:1896–902.
   PubMed Web of Science ®Google Scholar
• (a) Garaj V, Puccetti L, Fasolis G, et al. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Bioorg Med Chem Lett 2005; 15:3102–8.
   PubMed Web of Science ®Google Scholar
  (b)Sentürk M, Gülçin I, Beydemir S, et al. In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Des 2011; 77:494–9.
   PubMed Web of Science ®Google Scholar
  (c) Gieling RG, Babur M, Mamnani L, et al. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. J Med Chem 2012;55:5591–600.
   PubMed Web of Science ®Google Scholar
• (a) Koca M, Ertürk AS, Umaz A. Microwave-assisted intermolecular aldol condensation: Efficient one-step synthesis of 3-acetyl isocoumarin and optimization of different reaction conditions. Arab J Chem 2018;11:538–45.
   Web of Science ®Google Scholar
  (b) Kurt A, Kilinc I, Koca M. Preparation of copolymer systems of 2-Isocoumarin-3-yl)-2-oxoethyl metacrylate with methyl methacrylate and thermal decomposition kinetics. Iran J Sci Technol Trans A Sci 2020;44:1039–50.
   Web of Science ®Google Scholar
  (c) Reddy GM, Garcia JR, Yuvaraja G, et al. Design, synthesis of tri-substituted pyrazole derivatives as promising antimicrobial agents and investigation of structure activity relationships. J Heterocyclic Chem 2020;57:2288–96.
   Web of Science ®Google Scholar
  (d) Karuk Elmas SN, Dincer ZE, Erturk AS, et al. A novel fluorescent probe based on isocoumarin for Hg2+ and Fe3+ ions and its application in live-cell imaging. Spectrochim Acta A Mol Biomol Spectrosc 2020;224:117402.
   PubMed Web of Science ®Google Scholar
  (e) Shablykina OV, Shablykin OV, Ishchenko VV, et al. Synthesis of 3-hetaryl-1H-isochromen-1-ones based on 3-(2-bromoacetyl)-1H-isochromen-1-one. Chem Heterocycl Compd 2013;48:1621–7.
   Web of Science ®Google Scholar
  (f) Kurt A, Avcı HI, Koca M. Synthesis and characterization of a novel isocoumarin-derived polymer and the investigation of its thermal decomposıtıon kinetics. Maced J Chem Chem Eng 2018;37:173–84.
   Web of Science ®Google Scholar
• Kenchappa R, Bodke YD, Chandrashekar A, et al. Synthesis of coumarin derivatives containing pyrazole and indenone rings as potent antioxidant and antihyperglycemic agents. Arab J Chem 2017;10:3895–906.
   Web of Science ®Google Scholar
• Chodankar NK, Sequeira S, Seshadri S. Short communication synthesis of 3-hetarylcoumarins. Dye Pigment 1986;7:231–6.
   Web of Science ®Google Scholar
• (a) Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond) 2021; 135:1233–49.
   PubMed Web of Science ®Google Scholar
  (b) Supuran CT. Novel carbonic anhydrase inhibitors. Future Med Chem 2021; 13:1935–7.
   PubMed Web of Science ®Google Scholar
  (c) Supuran CT. Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs. 2022:30(12):1197–1208.
   Web of Science ®Google Scholar